Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-24

Clinical Trial Update: Improving Physical Ability and Cellular Senescence Elimination in HIV [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating improvements in physical ability and targeting cellular senescence in people with HIV and frailty-related aging cond…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV, Frailty | Phase 2 | Status: ACTIVE_NOT_RECRUITING